Upregulation of Phosphodiesterase type 5 in the Hyperplastic Prostate

Both erectile dysfunction (ED) and lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH) are common in the aging male. Numerous clinical trials have demonstrated the efficacy and safety of phosphodiesterase type 5 inhibitors (PDE5-Is) for treating LUTS/BPH with/without ED. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenhao, Zang, Ning, Jiang, Yaoming, Chen, Ping, Wang, Xinghuan, Zhang, Xinhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674741/
https://www.ncbi.nlm.nih.gov/pubmed/26657792
http://dx.doi.org/10.1038/srep17888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674741/
https://www.ncbi.nlm.nih.gov/pubmed/26657792
http://dx.doi.org/10.1038/srep17888

Ejemplares similares